
Validea's guru fundamental report indicates that UNITEDHEALTH GROUP INC (UNH) receives a 69% rating based on the Martin Zweig Growth Investor model, which favors growth stocks with accelerating earnings and sales, reasonable valuations, and low debt; UNH passes several tests, including P/E ratio, revenue growth relative to EPS, and sales growth rate, but fails in areas such as earnings persistence and long-term EPS growth. The Zweig strategy, which has historically shown strong risk-adjusted returns, suggests moderate interest in UNH based on its fundamentals and valuation.
UnitedHealth Group Inc. (UNH) scores a 69% rating based on Validea's Martin Zweig Growth Investor model, indicating a level of interest below the strategy's typical thresholds for strong consideration (80% for some interest, 90% for strong interest). The model, which seeks growth stocks with persistent accelerating earnings, strong sales growth, reasonable valuations, and low debt, finds UNH passing several key tests: P/E ratio, revenue growth relative to EPS growth, sales growth rate, current quarter earnings, positive earnings growth rate for the current quarter, and current quarter EPS growth surpassing both the prior three quarters and its historical growth rate. Insider transactions also meet the model's criteria. However, UNH fails on critical aspects such as quarterly earnings one year ago, the earnings growth rate over the past several quarters, earnings persistence, and long-term EPS growth. This mixed performance suggests that while UNH exhibits some positive current growth characteristics and a reasonable valuation according to the P/E metric, it falls short on demonstrating the consistent, accelerating, and persistent earnings growth profile highly valued by the Zweig strategy, leading to the moderate overall score.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
Neutral
Sentiment Score
-0.05
Ticker Sentiment